In focus · trending topic

Dravet Syndrome

2 stories · following the connections

Zogenix Provides Corporate Update and Reports Second Quarter 2016 Financial Results

By Nasdaq OMXAug 9, 2016, 8:01 PM UTC

Zogenix Receives Fast Track Designation From FDA for Development of ZX008 in Dravet Syndrome

By Nasdaq OMXJan 19, 2016, 1:00 PM UTC